FDA-Approved All-In-One Home Hemodialysis System – Attracted $125 Billion Investment
Hemodialysis system for home use that can receive dialysis treatment at home as easily as electronic products by producing purified water and dialysate with electricity and water.
Intuitive interface increases price and ease of use and expects to benefit from the Trump administration's executive order focusing on home hemodialysis.
Outset Medical
Outset Medical is a pioneering medical technology company that manufactures medical equipment. The company reimagining dialysis for patients and health care providers. The innovative, compact, user-friendly Tablo Hemodialysis System can deliver both acute and chronic dialysis, wherever you need it.
Through the versatile, all-in-one Tablo Hemodialysis System, they are using innovative technology to drive service model innovation, aimed at reducing cost and transforming the patient care experience. The system comes equipped with wireless data, sensor-based automation, and an animated touchscreen to make the system as easy to use as possible.
General Information
- Headquarters : San Jose, CA
- Founders : Michael Baker
- Categories : Health Care, Health Diagnostics, Medical, Medical Device
- Founded : 2003
- Contact : question@outsetmedical.com
Funding
- Investors: D1 Capital Partners, Fidelity, Partner Fund Management, T. Rowe Price
- Funding Rounds (7) - $447.3M
- Feb 5, 2020 Series E / $125M
- Aug 28, 2018 Series D / $132M
- Jul 5, 2017 Debt Financing / $4.3M
- May 3, 2017 Series C / $76.5M
- Jun 9, 2015 Debt Financing / $45M
- May 20, 2015 Series B / $60M
- Feb 22, 2010 Venture Round / $4.5M
Source: Outset Medical
👉• Web: http://outsetmedical.com
👉• Video: Outset Medical - YouTube
0 Comments